Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/27/2905083/0/en/ADC-Therapeutics-Set-to-Join-Russell-2000-and-Russell-3000-Indexes.html
https://www.globenewswire.com/news-release/2024/06/03/2892590/0/en/ADC-Therapeutics-Makes-Grants-to-New-Employees-Under-Inducement-Plan.html
https://www.globenewswire.com/news-release/2024/05/30/2890638/0/en/ADC-Therapeutics-to-Participate-in-the-Jefferies-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/05/15/2882296/0/en/ADC-Therapeutics-to-Participate-in-the-H-C-Wainwright-2nd-Annual-BioConnect-Investor-Conference-at-NASDAQ.html
https://www.globenewswire.com/news-release/2024/05/09/2878634/0/en/ADC-Therapeutics-to-Participate-in-2024-RBC-Capital-Markets-Global-Healthcare-Conference.html
https://www.fiercepharma.com/pharma/adc-therapeutics-touts-early-zynlonta-results-marginal-zone-lymphoma-raises-105m-through
https://www.globenewswire.com/news-release/2024/05/06/2875709/0/en/ADC-Therapeutics-Announces-105-Million-Underwritten-Offering-of-Common-Shares-and-Pre-Funded-Warrants.html
https://www.globenewswire.com/news-release/2024/05/06/2875646/0/en/ADC-Therapeutics-Reports-First-Quarter-2024-Financial-Results-and-Provides-Business-Updates.html
https://www.globenewswire.com/news-release/2024/05/06/2875641/0/en/ADC-Therapeutics-Announces-Initial-Data-from-Investigator-Initiated-Phase-2-Clinical-Trial-of-ZYNLONTA-in-Patients-with-Relapsed-Refractory-Marginal-Zone-Lymphoma.html
https://www.globenewswire.com/news-release/2024/05/01/2873620/0/en/ADC-Therapeutics-Makes-Grants-to-New-Employees-Under-Inducement-Plan.html